within 90 days of the end of a clinical trial the sponsor shall notify the competent authorities of the Member State or Member States concerned and the Ethics Committee that the clinical trial has ended.
naročnik v 90 dneh od zaključka kliničnega preskušanja pristojne organe zadevne države članice ali zadevnih držav članic in Odbor za etiko obvesti, da je preskušanje zaključeno.